Trials / Unknown
UnknownNCT00787774
Integrase Resistance Analysis in HIV Patients Who Interrupted Raltegravir Due to Incomplete Viral Suppression
Integrase Resistance Analysis in Treated Experienced HIV Patients Who Interrupted Raltegravir Due to Incomplete Viral Suppression
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Hospital Clinic of Barcelona · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Prospective study to evaluate the potential persistent viral effect of raltegravir in 20 treatment experienced HIV patients with incomplete viral suppression
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | resume raltegravir | resume raltegravir after 16 weeks of stopping |
Timeline
- Start date
- 2008-11-01
- Primary completion
- 2010-01-01
- Completion
- 2010-01-01
- First posted
- 2008-11-10
- Last updated
- 2010-03-31
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT00787774. Inclusion in this directory is not an endorsement.